Early Asbestos Awareness and Industry Suppression - Revision history

MesotheliomaSupport: Add Science History Institute citation for Nellie Kershaw case (second-round backlink outreach)

2026-03-11T03:52:49Z

Add Science History Institute citation for Nellie Kershaw case (second-round backlink outreach)

MesotheliomaSupport: Internal linking: added 7 wiki links

2026-02-20T21:00:05Z

Internal linking: added 7 wiki links

MesotheliomaSupport: New page: Early Asbestos Awareness & Industry Suppression (1900-1970) — medical evidence and corporate concealment

2026-02-07T02:07:30Z

New page: Early Asbestos Awareness & Industry Suppression (1900-1970) — medical evidence and corporate concealment

Show changes

← Older revision		Revision as of 03:52, 11 March 2026
Line 15:		Line 15:

	'''Industry Cover-Up Peak:''' 1929–1960s		'''Industry Cover-Up Peak:''' 1929–1960s
	([[Johns-Manville]] & "Asbestos Pentagon")		(Johns-Manville & "Asbestos Pentagon")

	'''Game-Changing Publication:''' 1964		'''Game-Changing Publication:''' 1964
	([[Dr. Irving Selikoff]], JAMA)		(Dr. Irving Selikoff, JAMA)

	'''First Federal Standard:''' 1971		'''First Federal Standard:''' 1971
Line 31:		Line 31:
	== Executive Summary ==		== Executive Summary ==

	The history of asbestos in the twentieth century represents one of the most consequential instances of deliberate suppression of medical evidence in modern industrial history. Beginning with Dr. H. Montague Murray's 1899 clinical observations at Charing Cross Hospital in London, scientific evidence linking asbestos inhalation to severe lung disease accumulated steadily throughout the early 1900s. By 1930, the landmark Merewether and Price government study in the United Kingdom documented asbestos-related disease in 81 percent of workers with twenty or more years of exposure. Yet, rather than protecting workers, major manufacturers—led by Johns-Manville, [[Raybestos]]-Manhattan, Owens-Corning, Unarco, and Celotex (the "Asbestos Pentagon")—systematically suppressed, altered, and concealed medical findings for four decades.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> This deliberate campaign of denial persisted until Dr. Irving Selikoff's landmark 1964 publication in the Journal of the American Medical Association shifted public and regulatory attention irrevocably. The period from 1900 to 1970 reveals not a gap in knowledge, but a chasm between what industry knew and what it allowed the public to learn.		The history of asbestos in the twentieth century represents one of the most consequential instances of deliberate suppression of medical evidence in modern industrial history. Beginning with Dr. H. Montague Murray's 1899 clinical observations at Charing Cross Hospital in London, scientific evidence linking asbestos inhalation to severe lung disease accumulated steadily throughout the early 1900s. By 1930, the landmark Merewether and Price government study in the United Kingdom documented asbestos-related disease in 81 percent of workers with twenty or more years of exposure. Yet, rather than protecting workers, major manufacturers—led by Johns-Manville, Raybestos-Manhattan, Owens-Corning, Unarco, and Celotex (the "Asbestos Pentagon")—systematically suppressed, altered, and concealed medical findings for four decades.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> This deliberate campaign of denial persisted until Dr. Irving Selikoff's landmark 1964 publication in the Journal of the American Medical Association shifted public and regulatory attention irrevocably. The period from 1900 to 1970 reveals not a gap in knowledge, but a chasm between what industry knew and what it allowed the public to learn.

	== Key Facts: Early Asbestos Medical Recognition & Industry Suppression ==		== Key Facts: Early Asbestos Medical Recognition & Industry Suppression ==
Line 49:		Line 49:
	* '''1935:''' Sumner Simpson memo: "The less said about asbestos, the better off we are"—discovered in litigation 1977		* '''1935:''' Sumner Simpson memo: "The less said about asbestos, the better off we are"—discovered in litigation 1977
	* '''1949:''' Johns-Manville Medical Director Dr. Kenneth Smith writes memo recommending non-disclosure of disease to workers		* '''1949:''' Johns-Manville Medical Director Dr. Kenneth Smith writes memo recommending non-disclosure of disease to workers
	* '''1964:''' Dr. Irving Selikoff publishes "[[Asbestos Exposure]] and Neoplasia" in JAMA documenting 45 lung cancer deaths vs. 6.6 expected in 632 ~~[[Insulation Workers\|~~insulation workers]]		* '''1964:''' Dr. Irving Selikoff publishes "Asbestos Exposure and Neoplasia" in JAMA documenting 45 lung cancer deaths vs. 6.6 expected in 632 insulation workers
	* '''1964:''' New York Academy of Sciences conference "Biological Effects of Asbestos" shifts national conversation		* '''1964:''' New York Academy of Sciences conference "Biological Effects of Asbestos" shifts national conversation
	* '''1970:''' Asbestos Information Association formed as industry public relations response		* '''1970:''' Asbestos Information Association formed as industry public relations response
Line 63:		Line 63:
	Twenty-five years later, Dr. W.E. Cooke of Croydon, England brought renewed attention to the disease through a landmark case report published in the British Medical Journal in 1924.<ref name="cooke_1924">[https://mesothelioma.net/asbestos-exposure/ Asbestos Exposure], Mesothelioma.net</ref> Cooke's article, titled "Fibrosis of the Lungs Due to Inhalation of Asbestos Dust," presented detailed clinical and radiological findings in a 33-year-old woman who had worked in asbestos textile manufacturing. The article's scientific rigor and clear documentation drew professional attention and helped establish asbestos-related lung disease as a recognized occupational condition within the medical community.		Twenty-five years later, Dr. W.E. Cooke of Croydon, England brought renewed attention to the disease through a landmark case report published in the British Medical Journal in 1924.<ref name="cooke_1924">[https://mesothelioma.net/asbestos-exposure/ Asbestos Exposure], Mesothelioma.net</ref> Cooke's article, titled "Fibrosis of the Lungs Due to Inhalation of Asbestos Dust," presented detailed clinical and radiological findings in a 33-year-old woman who had worked in asbestos textile manufacturing. The article's scientific rigor and clear documentation drew professional attention and helped establish asbestos-related lung disease as a recognized occupational condition within the medical community.

	The case of Nellie Kershaw, a young asbestos worker in the United Kingdom, became iconic in establishing legal and medical recognition of the disease. Kershaw~~'s case proceeded through the British workers'~~ compensation ~~system~~, and her ~~condition was officially recognized as related to asbestos exposure~~. Following ~~this determination~~, in 1927, the term "asbestosis" was formally coined by the medical profession to describe the disease.~~<ref name="dandell_kershaw">[https://dandell.com/mesothelioma/lung-cancer-asbestos-compensation/ Lung Cancer & Asbestos Compensation], Danziger & De Llano</ref>~~ By the late 1920s, therefore, medical science in Europe had clearly identified a new occupational disease and given it a name.		The case of Nellie Kershaw, a young asbestos worker in the United Kingdom, became iconic in establishing legal and medical recognition of the disease. Born near Manchester in 1891, Kershaw began working in an asbestos textile factory at age twelve, inhaling asbestos dust for nearly two decades as she managed machines that twisted asbestos strands into thread.<ref name="sciencehistory_kershaw" /> By 1920, she experienced constant fatigue and coughed up blood; within two years her lungs had deteriorated so severely that she was bedridden at age thirty-one. Kershaw died in 1924 at age thirty-three, nearly destitute after her employer, Turner Brothers Asbestos, and their insurer refused compensation. Her autopsy revealed scarred lung tissue that appeared grey or blue-black, and microscopic examination found fibers matching those from her factory.<ref name="dandell_kershaw" /> Following the Kershaw case and subsequent medical inquiry, in 1927, the term "asbestosis" was formally coined by the medical profession to describe the disease. By the late 1920s, therefore, medical science in Europe had clearly identified a new occupational disease and given it a name.

	== What Did the Merewether & Price Report Reveal in 1930? ==		== What Did the Merewether & Price Report Reveal in 1930? ==
Line 69:		Line 69:
	The most important early epidemiological study came from the British government in 1930, conducted by H.E. Merewether and C.W. Price. This landmark study would become the watershed moment in asbestos disease recognition—and the turning point at which industry suppression intensified dramatically.		The most important early epidemiological study came from the British government in 1930, conducted by H.E. Merewether and C.W. Price. This landmark study would become the watershed moment in asbestos disease recognition—and the turning point at which industry suppression intensified dramatically.

	Per [[Mesothelioma]] Lawyer Center, Merewether and Price conducted a comprehensive health survey of 363 asbestos workers employed in the United Kingdom.<ref name="merewether_1930">[https://mesotheliomalawyercenter.org/asbestos/laws-regulations/ Asbestos Laws & Regulations], Mesothelioma Lawyer Center</ref> Their findings were stark and undeniable: 25 percent of all asbestos workers showed clinical evidence of asbestos-related disease. As documented by Danziger & De Llano, more striking still, among workers with twenty or more years of exposure, the prevalence reached 81 percent.<ref name="dandell_merewether">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth], Danziger & De Llano</ref> The study demonstrated dose-response relationships and provided quantitative evidence that asbestos exposure was not a minor occupational concern, but a significant health threat.		Per Mesothelioma Lawyer Center, Merewether and Price conducted a comprehensive health survey of 363 asbestos workers employed in the United Kingdom.<ref name="merewether_1930">[https://mesotheliomalawyercenter.org/asbestos/laws-regulations/ Asbestos Laws & Regulations], Mesothelioma Lawyer Center</ref> Their findings were stark and undeniable: 25 percent of all asbestos workers showed clinical evidence of asbestos-related disease. As documented by Danziger & De Llano, more striking still, among workers with twenty or more years of exposure, the prevalence reached 81 percent.<ref name="dandell_merewether">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth], Danziger & De Llano</ref> The study demonstrated dose-response relationships and provided quantitative evidence that asbestos exposure was not a minor occupational concern, but a significant health threat.

	The British government responded promptly. According to Mesothelioma Lawyer Center's legal review, in 1931, the United Kingdom enacted the Asbestos Industry Regulations, establishing workplace standards, medical monitoring requirements, and worker notification protocols.<ref name="uk_regs_1931">[https://mesotheliomalawyercenter.org/asbestos/manufacturers/ Asbestos Manufacturers], Mesothelioma Lawyer Center</ref> The Merewether & Price study had catalyzed regulatory action. However, in the United States, no comparable federal response occurred. American manufacturers, alarmed by the British government's regulatory response, instead pursued a strategy of denial, suppression, and control of information.		The British government responded promptly. According to Mesothelioma Lawyer Center's legal review, in 1931, the United Kingdom enacted the Asbestos Industry Regulations, establishing workplace standards, medical monitoring requirements, and worker notification protocols.<ref name="uk_regs_1931">[https://mesotheliomalawyercenter.org/asbestos/manufacturers/ Asbestos Manufacturers], Mesothelioma Lawyer Center</ref> The Merewether & Price study had catalyzed regulatory action. However, in the United States, no comparable federal response occurred. American manufacturers, alarmed by the British government's regulatory response, instead pursued a strategy of denial, suppression, and control of information.
Line 102:		Line 102:
	=== Trade Magazine and Trade Association Control ===		=== Trade Magazine and Trade Association Control ===

	Industry control extended into the professional publications that asbestos manufacturers and workers relied upon for information. As Danziger & De Llano notes, Trade magazines such as ''Asbestos Magazine'', which reached workers, managers, and professionals in the industry, exercised editorial control to suppress articles and warnings about health hazards.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> Proposed articles documenting ~~[[Asbestos Health Effects\|~~asbestos health effects]] were rejected from publication. Industry advertisements promoting asbestos products as safe dominated the trade press, while contrary medical evidence was systematically excluded.		Industry control extended into the professional publications that asbestos manufacturers and workers relied upon for information. As Danziger & De Llano notes, Trade magazines such as ''Asbestos Magazine'', which reached workers, managers, and professionals in the industry, exercised editorial control to suppress articles and warnings about health hazards.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> Proposed articles documenting asbestos health effects were rejected from publication. Industry advertisements promoting asbestos products as safe dominated the trade press, while contrary medical evidence was systematically excluded.

	In December 1970, as public and regulatory attention to asbestos hazards began to intensify, the industry established the Asbestos Information Association (AIA) to coordinate public relations efforts and manage the narrative about asbestos safety. As reported by Mesothelioma Lawyer Center, the AIA's mission was explicitly to counter emerging health concerns and maintain market demand for asbestos products.<ref name="aia_formation">[https://mesotheliomalawyercenter.org/asbestos/exposure/ Asbestos Exposure], Mesothelioma Lawyer Center</ref>		In December 1970, as public and regulatory attention to asbestos hazards began to intensify, the industry established the Asbestos Information Association (AIA) to coordinate public relations efforts and manage the narrative about asbestos safety. As reported by Mesothelioma Lawyer Center, the AIA's mission was explicitly to counter emerging health concerns and maintain market demand for asbestos products.<ref name="aia_formation">[https://mesotheliomalawyercenter.org/asbestos/exposure/ Asbestos Exposure], Mesothelioma Lawyer Center</ref>
Line 213:		Line 213:
	<ref name="cooke_1924">[https://mesothelioma.net/asbestos-exposure/ Asbestos Exposure], Mesothelioma.net</ref>		<ref name="cooke_1924">[https://mesothelioma.net/asbestos-exposure/ Asbestos Exposure], Mesothelioma.net</ref>

			<ref name="sciencehistory_kershaw">[https://www.sciencehistory.org/stories/disappearing-pod/how-asbestos-fell-from-grace/ How Asbestos Fell from Grace], Science History Institute</ref>
	<ref name="dandell_kershaw">[https://dandell.com/mesothelioma/lung-cancer-asbestos-compensation/ Lung Cancer & Asbestos Compensation], Danziger & De Llano</ref>		<ref name="dandell_kershaw">[https://dandell.com/mesothelioma/lung-cancer-asbestos-compensation/ Lung Cancer & Asbestos Compensation], Danziger & De Llano</ref>

← Older revision		Revision as of 21:00, 20 February 2026
Line 15:		Line 15:

	'''Industry Cover-Up Peak:''' 1929–1960s		'''Industry Cover-Up Peak:''' 1929–1960s
	(Johns-Manville & "Asbestos Pentagon")		([[Johns-Manville]] & "Asbestos Pentagon")

	'''Game-Changing Publication:''' 1964		'''Game-Changing Publication:''' 1964
	(Dr. Irving Selikoff, JAMA)		([[Dr. Irving Selikoff]], JAMA)

	'''First Federal Standard:''' 1971		'''First Federal Standard:''' 1971
Line 31:		Line 31:
	== Executive Summary ==		== Executive Summary ==

	The history of asbestos in the twentieth century represents one of the most consequential instances of deliberate suppression of medical evidence in modern industrial history. Beginning with Dr. H. Montague Murray's 1899 clinical observations at Charing Cross Hospital in London, scientific evidence linking asbestos inhalation to severe lung disease accumulated steadily throughout the early 1900s. By 1930, the landmark Merewether and Price government study in the United Kingdom documented asbestos-related disease in 81 percent of workers with twenty or more years of exposure. Yet, rather than protecting workers, major manufacturers—led by Johns-Manville, Raybestos-Manhattan, Owens-Corning, Unarco, and Celotex (the "Asbestos Pentagon")—systematically suppressed, altered, and concealed medical findings for four decades.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> This deliberate campaign of denial persisted until Dr. Irving Selikoff's landmark 1964 publication in the Journal of the American Medical Association shifted public and regulatory attention irrevocably. The period from 1900 to 1970 reveals not a gap in knowledge, but a chasm between what industry knew and what it allowed the public to learn.		The history of asbestos in the twentieth century represents one of the most consequential instances of deliberate suppression of medical evidence in modern industrial history. Beginning with Dr. H. Montague Murray's 1899 clinical observations at Charing Cross Hospital in London, scientific evidence linking asbestos inhalation to severe lung disease accumulated steadily throughout the early 1900s. By 1930, the landmark Merewether and Price government study in the United Kingdom documented asbestos-related disease in 81 percent of workers with twenty or more years of exposure. Yet, rather than protecting workers, major manufacturers—led by Johns-Manville, [[Raybestos]]-Manhattan, Owens-Corning, Unarco, and Celotex (the "Asbestos Pentagon")—systematically suppressed, altered, and concealed medical findings for four decades.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> This deliberate campaign of denial persisted until Dr. Irving Selikoff's landmark 1964 publication in the Journal of the American Medical Association shifted public and regulatory attention irrevocably. The period from 1900 to 1970 reveals not a gap in knowledge, but a chasm between what industry knew and what it allowed the public to learn.

	== Key Facts: Early Asbestos Medical Recognition & Industry Suppression ==		== Key Facts: Early Asbestos Medical Recognition & Industry Suppression ==
Line 49:		Line 49:
	* '''1935:''' Sumner Simpson memo: "The less said about asbestos, the better off we are"—discovered in litigation 1977		* '''1935:''' Sumner Simpson memo: "The less said about asbestos, the better off we are"—discovered in litigation 1977
	* '''1949:''' Johns-Manville Medical Director Dr. Kenneth Smith writes memo recommending non-disclosure of disease to workers		* '''1949:''' Johns-Manville Medical Director Dr. Kenneth Smith writes memo recommending non-disclosure of disease to workers
	* '''1964:''' Dr. Irving Selikoff publishes "Asbestos Exposure and Neoplasia" in JAMA documenting 45 lung cancer deaths vs. 6.6 expected in 632 insulation workers		* '''1964:''' Dr. Irving Selikoff publishes "[[Asbestos Exposure]] and Neoplasia" in JAMA documenting 45 lung cancer deaths vs. 6.6 expected in 632 [[Insulation Workers\|insulation workers]]
	* '''1964:''' New York Academy of Sciences conference "Biological Effects of Asbestos" shifts national conversation		* '''1964:''' New York Academy of Sciences conference "Biological Effects of Asbestos" shifts national conversation
	* '''1970:''' Asbestos Information Association formed as industry public relations response		* '''1970:''' Asbestos Information Association formed as industry public relations response
Line 69:		Line 69:
	The most important early epidemiological study came from the British government in 1930, conducted by H.E. Merewether and C.W. Price. This landmark study would become the watershed moment in asbestos disease recognition—and the turning point at which industry suppression intensified dramatically.		The most important early epidemiological study came from the British government in 1930, conducted by H.E. Merewether and C.W. Price. This landmark study would become the watershed moment in asbestos disease recognition—and the turning point at which industry suppression intensified dramatically.

	Per Mesothelioma Lawyer Center, Merewether and Price conducted a comprehensive health survey of 363 asbestos workers employed in the United Kingdom.<ref name="merewether_1930">[https://mesotheliomalawyercenter.org/asbestos/laws-regulations/ Asbestos Laws & Regulations], Mesothelioma Lawyer Center</ref> Their findings were stark and undeniable: 25 percent of all asbestos workers showed clinical evidence of asbestos-related disease. As documented by Danziger & De Llano, more striking still, among workers with twenty or more years of exposure, the prevalence reached 81 percent.<ref name="dandell_merewether">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth], Danziger & De Llano</ref> The study demonstrated dose-response relationships and provided quantitative evidence that asbestos exposure was not a minor occupational concern, but a significant health threat.		Per [[Mesothelioma]] Lawyer Center, Merewether and Price conducted a comprehensive health survey of 363 asbestos workers employed in the United Kingdom.<ref name="merewether_1930">[https://mesotheliomalawyercenter.org/asbestos/laws-regulations/ Asbestos Laws & Regulations], Mesothelioma Lawyer Center</ref> Their findings were stark and undeniable: 25 percent of all asbestos workers showed clinical evidence of asbestos-related disease. As documented by Danziger & De Llano, more striking still, among workers with twenty or more years of exposure, the prevalence reached 81 percent.<ref name="dandell_merewether">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth], Danziger & De Llano</ref> The study demonstrated dose-response relationships and provided quantitative evidence that asbestos exposure was not a minor occupational concern, but a significant health threat.

	The British government responded promptly. According to Mesothelioma Lawyer Center's legal review, in 1931, the United Kingdom enacted the Asbestos Industry Regulations, establishing workplace standards, medical monitoring requirements, and worker notification protocols.<ref name="uk_regs_1931">[https://mesotheliomalawyercenter.org/asbestos/manufacturers/ Asbestos Manufacturers], Mesothelioma Lawyer Center</ref> The Merewether & Price study had catalyzed regulatory action. However, in the United States, no comparable federal response occurred. American manufacturers, alarmed by the British government's regulatory response, instead pursued a strategy of denial, suppression, and control of information.		The British government responded promptly. According to Mesothelioma Lawyer Center's legal review, in 1931, the United Kingdom enacted the Asbestos Industry Regulations, establishing workplace standards, medical monitoring requirements, and worker notification protocols.<ref name="uk_regs_1931">[https://mesotheliomalawyercenter.org/asbestos/manufacturers/ Asbestos Manufacturers], Mesothelioma Lawyer Center</ref> The Merewether & Price study had catalyzed regulatory action. However, in the United States, no comparable federal response occurred. American manufacturers, alarmed by the British government's regulatory response, instead pursued a strategy of denial, suppression, and control of information.
Line 102:		Line 102:
	=== Trade Magazine and Trade Association Control ===		=== Trade Magazine and Trade Association Control ===

	Industry control extended into the professional publications that asbestos manufacturers and workers relied upon for information. As Danziger & De Llano notes, Trade magazines such as ''Asbestos Magazine'', which reached workers, managers, and professionals in the industry, exercised editorial control to suppress articles and warnings about health hazards.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> Proposed articles documenting asbestos health effects were rejected from publication. Industry advertisements promoting asbestos products as safe dominated the trade press, while contrary medical evidence was systematically excluded.		Industry control extended into the professional publications that asbestos manufacturers and workers relied upon for information. As Danziger & De Llano notes, Trade magazines such as ''Asbestos Magazine'', which reached workers, managers, and professionals in the industry, exercised editorial control to suppress articles and warnings about health hazards.<ref name="dandell_suppression">[https://dandell.com/mesothelioma/when-did-asbestos-manufacturers-know-the-truth-they-hid/ When Did Asbestos Manufacturers Know the Truth—and Why Did They Hide It?], Danziger & De Llano</ref> Proposed articles documenting [[Asbestos Health Effects\|asbestos health effects]] were rejected from publication. Industry advertisements promoting asbestos products as safe dominated the trade press, while contrary medical evidence was systematically excluded.

	In December 1970, as public and regulatory attention to asbestos hazards began to intensify, the industry established the Asbestos Information Association (AIA) to coordinate public relations efforts and manage the narrative about asbestos safety. As reported by Mesothelioma Lawyer Center, the AIA's mission was explicitly to counter emerging health concerns and maintain market demand for asbestos products.<ref name="aia_formation">[https://mesotheliomalawyercenter.org/asbestos/exposure/ Asbestos Exposure], Mesothelioma Lawyer Center</ref>		In December 1970, as public and regulatory attention to asbestos hazards began to intensify, the industry established the Asbestos Information Association (AIA) to coordinate public relations efforts and manage the narrative about asbestos safety. As reported by Mesothelioma Lawyer Center, the AIA's mission was explicitly to counter emerging health concerns and maintain market demand for asbestos products.<ref name="aia_formation">[https://mesotheliomalawyercenter.org/asbestos/exposure/ Asbestos Exposure], Mesothelioma Lawyer Center</ref>